JAC Advance Access originally published online on May 30, 2006
Journal of Antimicrobial Chemotherapy 2006 58(2):413-417; doi:10.1093/jac/dkl185
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
European Surveillance of Antimicrobial Consumption (ESAC): outpatient cephalosporin use in Europe
1 Department of General Practice, University of Antwerp Antwerp, Belgium 2 Fund for Scientific Research—Flanders Brussels, Belgium 3 Laboratory of Microbiology, University of Antwerp Antwerp, Belgium 4 Unit of Epidemiology, Scientific Institute of Public Health Brussels, Belgium 5 Laboratory of Microbiology, Leiden University Medical Center Leiden, The Netherlands
Received 23 August 2005; returned 2 November 2005; revised 12 April 2006; accepted 16 April 2006
*Correspondence address. Laboratory of Microbiology, University of Antwerp, Universiteitsplein 1, 2610 Antwerp, Belgium. Tel: +32-3-820-2751; Fax: +32-3-820-2752; E-mail: samuel.coenen{at}ua.ac.be
Background: Data on outpatient cephalosporin use in Europe were collected from 25 countries within the ESAC project, funded by DG SANCO of the European Commission, using the WHO ATC/DDD methodology.
Methods: For the period 1997–2003, data on outpatient use of systemic cephalosporins aggregated at the level of the active substance were collected and expressed in DDD (WHO, version 2004) per 1000 inhabitants per day (DID). Use was analysed in detail, using the new ATC codes J01DB, J01DC, J01DD and J01DE, introduced in the 2005 issue of the WHO ATC index and assigned to the four cephalosporin generations.
Results: Total outpatient cephalosporin use in 2003 varied by a factor of 270 between the country with the highest (6.18 DID in Greece) and lowest (0.02 DID in Denmark) use. First-, second- and third-generation cephalosporins were used most in 6, 16 and 3 countries, respectively. We observed fourth-generation use (mainly cefepime) in ambulatory care in 11 countries. From 1997 to 2003 cephalosporin use decreased in 13 countries, in France by more than 1 DID. A relative increase of second-generation (mainly cefuroxime) or third-generation use (mainly cefpodoxime or cefixime) by more than 10% in 12 countries coincided with an equally large decrease of first-generation use in eight countries (mainly cefadroxil, cefalexin or cefatrizine). In six countries, first-generation use increased, second-generation use decreased or both occurred.
Conclusion: The new ATC codes allow a more detailed description of outpatient cephalosporin use. The variation in antibiotic use in Europe is most extreme for this class of antibiotics, suggesting that in many countries in Europe these antibiotics are prescribed inappropriately.
Keywords: antibiotic use , cephalosporins , drug consumption , pharmacoepidemiology , ambulatory care , Europe
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. Coenen, A. Muller, N. Adriaenssens, V. Vankerckhoven, E. Hendrickx, H. Goossens, and on behalf of the ESAC Project Group European Surveillance of Antimicrobial Consumption (ESAC): outpatient parenteral antibiotic treatment in Europe J. Antimicrob. Chemother., July 1, 2009; 64(1): 200 - 205. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Dong, H. Yan, and D. Wang Antibiotic prescribing patterns in village health clinics across 10 provinces of Western China J. Antimicrob. Chemother., August 1, 2008; 62(2): 410 - 415. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. E. Mroczkowska and M. Barlow Fitness Trade-Offs in blaTEM Evolution Antimicrob. Agents Chemother., July 1, 2008; 52(7): 2340 - 2345. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Coenen, M. Ferech, F. M Haaijer-Ruskamp, C. C Butler, R. H Vander Stichele, T. J M Verheij, D. L Monnet, P. Little, H. Goossens, and the ESAC Project Group European Surveillance of Antimicrobial Consumption (ESAC): quality indicators for outpatient antibiotic use in Europe Qual. Saf. Health Care, December 1, 2007; 16(6): 440 - 445. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Ferech, S. Coenen, S. Malhotra-Kumar, K. Dvorakova, E. Hendrickx, C. Suetens, H. Goossens, and on behalf of the ESAC Project Group European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe J. Antimicrob. Chemother., August 1, 2006; 58(2): 401 - 407. [Abstract] [Full Text] [PDF]
|
|